| Title | The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Locatelli SL, Careddu G, Inghirami G, Castagna L, Sportelli P, Santoro A, Carlo-Stella C |
| Journal | Leukemia |
| Volume | 30 |
| Issue | 12 |
| Pagination | 2402-2405 |
| Date Published | 2016 12 |
| ISSN | 1476-5551 |
| Keywords | Brentuximab Vedotin, Cell Death, Drug Synergism, Enzyme Inhibitors, Heterocyclic Compounds, 4 or More Rings, Hodgkin Disease, Humans, Immunoconjugates, Mitosis, Phosphoinositide-3 Kinase Inhibitors |
| DOI | 10.1038/leu.2016.224 |
| Alternate Journal | Leukemia |
| PubMed ID | 27499137 |
Related Faculty:
Giorgio Inghirami, M.D.